Featured Research

from universities, journals, and other organizations

Common heart medications may also protect against Parkinson's disease, study finds

Date:
January 23, 2010
Source:
University of California - Los Angeles
Summary:
In the first large-scale population-based study of its kind, researchers have found that a specific type of medication used to treat such cardiovascular conditions as hypertension, angina and abnormal heart rhythms, may also decrease the risk of developing Parkinson's disease.

UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease.

In the first large-scale population-based study of its kind, Dr. Beate Ritz, professor of epidemiology at the UCLA School of Public Health, in collaboration with researchers from the Danish Cancer Society, found that a specific sub-class of dihydropyridine cardiovascular medications was associated with a 26 to 30 percent decrease in the risk of Parkinson's. The findings appear in an upcoming print edition of the journal Annals of Neurology and are currently available online.

Parkinson's disease, the second most common neurodegenerative disorder in the United States, is characterized by a loss of voluntary movement, the result of the death of neurons in an area of the brain known as the substantia nigra, which is involved in movement control.

Neurons of the substantia nigra that are important in Parkinson's are known to have calcium channels in their cell membranes. These calcium channels are structures that allow the cells to transmit electrical charges to each other. Muscles like the heart also contain calcium channels, and the opening of the calcium channel in the heart causes a muscle contraction.

Because cardiac and smooth muscles depend on calcium channels to function, substances that block or modify their action have been used for decades to treat hypertension, angina and arrhythmia in humans. In the heart, the dihydropyridine class of drugs acts on a specific type of channel known as the L-type. Within the dihydropyridine class is a sub-class of medications that can cross the blood-brain barrier, giving them the potential to act on neurons in the brain. It turns out that the neurons that degenerate in Parkinson's disease also contain a type of L-type calcium channel.

For their study, the researchers turned to Denmark, a country that provides its population with free and equal access to health care. Each health service-related event and prescription is recorded in a database using a unique personal identification number assigned to each Danish citizen at birth or the granting of citizenship.

Using this database, Ritz and her colleagues conducted a population-based, case-control study to evaluate medical histories and medication usage for 1,931 Parkinson's patients and 9,651 unaffected subjects for a period up to 12 years prior to the diagnosis of Parkinson's.

By separately evaluating different classes of a variety of drugs prescribed for hypertension, researchers found that only calcium channel blockers of the dihydropyridine sub-class that cross the blood-brain barrier were associated with a significant decrease in the risk of developing Parkinson's. Other classes of anti-hypertension medications, and dihydropyridines that were not able to cross the blood-brain barrier, were not associated with a lower risk.

"The key was to consider the mode of action of these drugs and whether or not they cross the blood-brain barrier," Ritz said. "Some do and some don't. We found that of all the hypertension medications taken by our study subjects, only the subset of dihydropyridine class drugs that cross into the brain, where they might be able to act on the calcium channels of neurons, provided a protective effect. This supports the idea that the mode of action of a given drug and whether it penetrates into the brain are important factors when studying drugs for neuroprotection."

Although the results are intriguing, Ritz cautions that more detailed studies and a more complete understanding of the biology underlying the action of these medications in the brain are warranted, particularly as some Parkinson's patients can suffer from low blood pressure, a condition which could be worsened by taking calcium channel blockers inappropriately.

In addition to Ritz, study authors included Shannon L. Rhodes and Lei Qian of UCLA, Dr. Eva Schernhammer of Brigham and Women's Hospital and Harvard Medical School, and Dr. Jorgen Olsen and Dr. Soren Friis of the Danish Cancer Society. The authors declare no conflict of interest.

The study was supported by a grant from the U.S. National Institute of Environmental Health Sciences. Dr. Ritz also receives support from the U.S. National Institute of Neurological Disorders and Stroke, as part of the Center for the Study of Parkinson's Disease in the UCLA Department of Neurology.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Los Angeles. "Common heart medications may also protect against Parkinson's disease, study finds." ScienceDaily. ScienceDaily, 23 January 2010. <www.sciencedaily.com/releases/2010/01/100122102849.htm>.
University of California - Los Angeles. (2010, January 23). Common heart medications may also protect against Parkinson's disease, study finds. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2010/01/100122102849.htm
University of California - Los Angeles. "Common heart medications may also protect against Parkinson's disease, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/01/100122102849.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins